ArticleBMC oral health2025
Enhancing PMMA properties: a comprehensive study of nanographene oxide and Boron nitride impact through In-Vitro analysis.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPolymethylmethacrylate is a commonly used biomaterial in dentistry. Although the material have been used for several years it has some limitations with respect to physical and mechanical properties. Researchers are exploring the potential of novel nanomaterials like nanographene oxide (nGO) and hexagonal boron nitride (hBN) to be used as a reinforcing agent. Therefore, the current investigation sought to evaluated physical, chemical, mechanical and antimicrobial potential of PMMA reinforced with nGO and hBN alone and synergistically as well.
methodsFour different groups were prepared including the control group (G1)0.2.5 wt% nGO was added to the liquid component (G2), 1 wt% hBN was added to the powder component (G3) and 2.5 wt % nGO with 1 wt % hBN combined (G4.) The resulting nanocomposite were characterized using microhardness, flexural and compressive strength analysis, contact angle analysis and degree of conversion was also calculated using Fourier Transform Infrared spectroscopy. The antimicrobial efficacy was assessed against Candida albicans. Statistical analysis was performed to determine the difference between the groups. One-way ANOVA was performed followed by Tukey's post hoc test for multiple comparisons between the groups.
resultsThe addition of nGO (17.67 ± 2.41 HV) ( p > 0.001) significantly increased the microhardness compared to the unmodified PMMA (15.91 ± 1.57 HV) (p > 0.001).The addition of both, nGO and hBN enhanced hydrophilicity (61.4° ± 2.36) and the surface roughness. Degree of conversion was found to be less than the control specimens for all experimental groups. G2 showed significantly less Candida albicans attachment compared to G1 (p < 0.05).
conclusionThe synergistic effect of nGO and hBN on PMMA shows promise for enhancing wettability and antimicrobial properties. However, the trade-off with lower polymerization conversion and increased roughness needs to be addressed. Future work could focus on optimizing the composition and processing conditions to maximize beneficial properties while minimizing negative impacts on physiochemical, mechanical performance and microbial adhesion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.